Bacterial Vaccines Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	170 Pages	Coherent Market Insights	June, 2023	CMI18049186

Best Price Guarantee
Price	from $4,500
Length	170 Pages
Publisher	Coherent Market Insights
Published Date	June, 2023
SKU	CMI18049186

Bacterial Vaccines Market, By Vaccine Type (Pertussis (Whooping Cough) Vaccines, Tetanus Vaccines, Diphtheria Vaccines, Pneumococcal Vaccines, Meningococcal Vaccines, Typhoid Vaccines, Tuberculosis (TB) Vaccines, Cholera Vaccines, Shigellosis Vaccines, Others), By Patient Age Group (Pediatric Vaccines (Infants, Children), Adolescent Vaccines, Adult Vaccines, Geriatric Vaccines), By Distribution Channel (Government Agencies and Programs, Hospitals and Clinics, Retail Pharmacies, Online Pharmacies, Others), By Route of Administration (Injectable Vaccines, Oral Vaccines, Nasal Vaccines), By End-User (Healthcare Providers, Vaccination Centers, Government and Public Health Organizations, Research Institutes and Academic Centers), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Bacterial vaccines contain mild or killed forms of bacteria that activate the immune system. This is a vital method for preventive medicine to fight infections like tuberculosis, cholera, anthrax, influenza, tetanus, meningitis, and typhoid. Several programs are carried out by governments and non-governmental organizations to spread awareness about the benefits of the preventive medicines including vaccines against infectious diseases.

Market Dynamics:

The global bacterial vaccines market is expected to grow at a substantial rate during the forecast period. This is mainly due to significant initiatives undertaken by governments across the globe to ensure that the preventive medicine for lethal infectious diseases is available for everyone. The market is also fueled by the increasing demand for vaccinations during pandemics. Moreover, the market is boosted by the launch of new DNA vaccines against infectious diseases. The Covid-19 pandemic has influenced the development of a variety of DNA vaccines and hence positively impacted the growth of the bacterial vaccines market. In addition to this, the rising incidence of antibiotic-resistant bacterial diseases is again supplementing the growth of bacterial vaccines market. This is prompting numerous players to invest in research activities focusing on developing more effective vaccines against infectious diseases.

However, lack of awareness regarding the bacterial disease is expected to hinder the market growth.

Key features of the study:

This report provides in-depth analysis of the global bacterial vaccines market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global bacterial vaccines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include GlaxoSmithKline plc, Pfizer Inc., Merck & Co., Inc., Sanofi Pasteur SA, Johnson & Johnson, Serum Institute of India Pvt. Ltd., Bharat Biotech International Limited, Biological E. Limited, Astellas Pharma Inc., Seqirus (CSL Limited), Mitsubishi Tanabe Pharma Corporation, Novavax, Inc., Bavarian Nordic, Emergent BioSolutions Inc., and Valneva SE

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global bacterial vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bacterial vaccines market

Detailed Segmentation:

Global Bacterial Vaccines Market, By Vaccine Type

Pertussis (Whooping Cough) Vaccines

Tetanus Vaccines

Diphtheria Vaccines

Pneumococcal Vaccines

Meningococcal Vaccines

Typhoid Vaccines

Tuberculosis (TB) Vaccines

Cholera Vaccines

Shigellosis Vaccines

Others

Global Bacterial Vaccines Market, By Patient Age Group

Pediatric Vaccines (Infants, Children)

Adolescent Vaccines

Adult Vaccines

Geriatric Vaccines

Global Bacterial Vaccines Market, By Distribution Channel

Government Agencies and Programs

Hospitals and Clinics

Retail Pharmacies

Online Pharmacies

Others

Global Bacterial Vaccines Market, By Route of Administration

Injectable Vaccines

Oral Vaccines

Nasal Vaccines

End User

Healthcare Providers

Vaccination Centers

Government and Public Health Organizations

Research Institutes and Academic Centers

Global Bacterial Vaccines Market, By Geography

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

Company Profiles

GlaxoSmithKline plc

Pfizer Inc.

Merck & Co., Inc.

Sanofi Pasteur SA

Johnson & Johnson

Serum Institute of India Pvt. Ltd.

Bharat Biotech International Limited

Biological E. Limited

Astellas Pharma Inc.

Seqirus (CSL Limited)

Mitsubishi Tanabe Pharma Corporation

Novavax, Inc.

Bavarian Nordic

Emergent BioSolutions Inc.

Valneva SE

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Vaccine Type; Market Snapshot, By Patient Age Group; Market Snapshot, By Distribution Channel; Market Snapshot, By Route of Administration; Market Snapshot, By Route of Administration; Market Snapshot, By Geography; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Increasing demand for vaccinations; Lack of awareness regarding bacterial disease; Growing initiatives by government; Impact Analysis; Key Highlights; Regulatory Scenario; Product launch/Approvals; PEST Analysis; PORTER’s Analysis; Merger and Acquisition Scenario
4. Global Bacterial Vaccines Market – Impact of Coronavirus (COVID-19) Pandemic: COVID-19 Epidemiology; Supply Side and Demand Side Analysis; Economic Impact
5. Global Bacterial Vaccines Market , By Vaccine Type, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Pertussis (Whooping Cough) Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Tetanus Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Diphtheria Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Pneumococcal Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Meningococcal Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Typhoid Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Tuberculosis (TB) Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Cholera Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Shigellosis Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
6. Global Bacterial Vaccines Market , By Patient Age Group, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Pediatric Vaccines (Infants, Children); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Adolescent Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Adult Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Geriatric Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
7. Global Bacterial Vaccines Market , By Distribution Channel, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Government Agencies and Programs; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Hospitals and Clinics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Retail Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Online Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
8. Global Bacterial Vaccines Market , By Route of Administration, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Injectable Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Oral Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Nasal Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
9. Global Bacterial Vaccines Market , By End User, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Healthcare Providers; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Vaccination Centers; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Government and Public Health Organizations; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Research Institutes and Academic Centers; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); 10. Global Bacterial Vaccines Market , By Region, 2023-2030, (US$ Bn); Introduction; Market Share Analysis, By Country, 2023 and 2030 (%); Y-o-Y Growth Analysis, For Country 2018 –2030; Country Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Middle East & Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); 11. Competitive Landscape; GlaxoSmithKline plc; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Pfizer Inc.; Merck & Co., Inc.; Sanofi Pasteur SA; Johnson & Johnson; Serum Institute of India Pvt. Ltd.; Bharat Biotech International Limited; Biological E. Limited; Astellas Pharma Inc.; Seqirus (CSL Limited); Mitsubishi Tanabe Pharma Corporation; Novavax, Inc.; Bavarian Nordic; Emergent BioSolutions Inc.; Valneva SE; Analyst Views; 12. Section; Research Methodology; About us; *Browse 24 market data tables and 28 figures on "Global Bacterial Vaccines Market” - Global forecast to 2030